Could a common drug beat aspirin at preventing second strokes?
NCT ID NCT07180472
First seen Nov 01, 2025 · Last updated May 03, 2026 · Updated 22 times
Summary
This study looks at whether cilostazol, a drug that helps blood flow, can prevent more strokes and slow brain damage than aspirin or clopidogrel in people with cerebral small vessel disease. About 632 adults who recently had a stroke caused by small artery blockages will take one of the three drugs for comparison. The goal is to find a safer, more effective way to reduce disability and improve long-term outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL SMALL VESSEL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.